Cerevance Named Karl Kieburtz Chief Medical Officer
Boston-based Cerevance hired Karl Kieburtz to lead the Phase 3 clinical development of its Parkinson's therapy.
Live Poll
Do you trust that new corporate leadership in medical companies leads to better patient outcomes?